	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S18-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
S11-PMC1361787	PMC1361787	12/2005	S11-PMC1361787	['maternal Intake of Carbohydrates and protein [3], Fatty Acids [4], and Micronutrients such as zinc [5-7], iron [2], magnesium [8-10], Calcium [11], riboflavin [4], and Vitamin C [12]MAY also have IMPORTANT EFFECTS on fetal growth and Perinatal outcomes.']	[('INCOMPLETE_EVIDENCE', 182), ('IMPORTANT_CONSIDERATION', 196), ('SUPERFICIAL_RELATIONSHIP', 206)]	3	[('GO_0007631', 'feeding behavior', 9, 'intake'), ('CHEBI_16646', 'carbohydrate', 19, 'carbohydrates'), ('CHEBI_35366', 'fatty acid', 50, 'fatty acids'), ('CHEBI_33839', 'macromolecule', 71, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 134, 'calcium'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin C'), ('GO_0036268', 'swimming', 234, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 234, 'perinatal')]
S46-PMC1888711	PMC1888711	5/2007	S46-PMC1888711	"['beneficial EFFECTS on Birth weight and the risk of Postpartum endometritis were SEEN for high-risk women"" [22].moderatedietary Vitamin A deficiencyvitamin a supplementation""further EVIDENCE on biologically PLAUSIBLE mechanisms of morbidity reduction such as reduced incidence of sepsis and/or reduced MARKERS of inflammation ARE NEEDED"" [60].lowdietary Micronutrient deficienciesmultiple Micronutrient supplementationone trial in tanzania showed no additional effect on markers of infection (C-Reactive Protein) compared with Iron and Folic Acid [15].lowanemia p. falciparum infectionanti-malarial Drugs""Drugs given routinely for malaria during Pregnancy reduce SEVERE Antenatal anaemia in the mother, and are ASSOCIATED with higher Birth weight in the baby and PROBABLY fewer Perinatal deaths.']"	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 181), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 301), ('FUTURE_WORK', 325), ('IMPORTANT_CONSIDERATION', 662), ('SUPERFICIAL_RELATIONSHIP', 710), ('PROBABLE_UNDERSTANDING', 762)]	9	[('GO_0007567', 'parturition', 22, 'birth'), ('GO_0007565', 'female pregnancy', 51, 'postpartum'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 353, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 388, 'micronutrient'), ('PR_000005890', 'crooked neck-like protein 1', 492, 'C-reactive protein'), ('CHEBI_24870', 'ion', 526, 'iron'), ('CHEBI_30751', 'formic acid', 535, 'folic acid'), ('CHEBI_23888', 'drug', 598, 'drugs'), ('CHEBI_23888', 'drug', 604, 'Drugs'), ('GO_0007565', 'female pregnancy', 645, 'pregnancy'), ('GO_0007567', 'parturition', 669, 'antenatal'), ('GO_0007567', 'parturition', 733, 'birth'), ('GO_0036268', 'swimming', 777, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 777, 'perinatal')]
S483-PMC2679409	PMC2679409	5/2009	S483-PMC2679409	['[96] performed a cochrane review of 5 trials of women who had received Vitamin A in Pregnancy (n = 23,426), but ONLY one study [101], REPORTED Perinatal mortality [loe: 1+] (additional file12).']	[('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 134)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin A'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('GO_0036268', 'swimming', 143, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 143, 'perinatal')]
S697-PMC2679409	PMC2679409	5/2009	S697-PMC2679409	['2005 meta-analysis: IMPACT of Vitamin A supplementation on Stillbirth and Perinatal mortality .']	[('SUPERFICIAL_RELATIONSHIP', 20)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin A'), ('GO_0001966', 'thigmotaxis', 59, 'stillbirth'), ('GO_0036268', 'swimming', 74, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 74, 'perinatal')]
S702-PMC2679409	PMC2679409	5/2009	S702-PMC2679409	['2002 review: IMPACT of Vitamin A supplementation on Stillbirth and Perinatal mortality .']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('GO_0001966', 'thigmotaxis', 52, 'stillbirth'), ('GO_0036268', 'swimming', 67, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 67, 'perinatal')]
S707-PMC2679409	PMC2679409	5/2009	S707-PMC2679409	['2005 meta-analysis: IMPACT of Vitamin A supplementation on Stillbirth and Perinatal mortality .']	[('SUPERFICIAL_RELATIONSHIP', 20)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin A'), ('GO_0001966', 'thigmotaxis', 59, 'stillbirth'), ('GO_0036268', 'swimming', 74, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 74, 'perinatal')]
S145-PMC3171895	PMC3171895	9/2011	S145-PMC3171895	['a CONSIDERABLE INTEREST exists regarding PREVENTION of Maternal and Perinatal Morbidity with Vitamins C and E. HOWEVER, the most RECENT meta-analysis of ten trials (6533 women) published in 2008 of antioxidant supplementation (including Vitamin C and e but also OTHER supplements such as Lycopene) SHOWED no difference in the relative risk (rr) of Preeclampsia (rr 0.73, 95% ci 0.51 to 1.06), Preterm Birth (before 37 weeks) (rr 1.10, 95% ci 0.99 to 1.22), sga infants (rr 0.83, 95% ci 0.62 to 1.11), or any baby death (rr 1.12, 95% ci 0.81 to 1.53) [7].']	[('ANOMALY_CURIOUS_FINDING', 2), ('ANOMALY_CURIOUS_FINDING', 15), ('IMPORTANT_CONSIDERATION', 15), ('SUPERFICIAL_RELATIONSHIP', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 129), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 262), ('INCOMPLETE_EVIDENCE', 298)]	8	[('GO_0007618', 'mating', 55, 'maternal ...'), ('GO_0019230', 'proprioception', 68, 'perinatal morbidity'), ('UBERON_0012101', 'perinatal stage', 68, 'perinatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamins C'), ('PR_000004900', 'complement C3', 102, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 108, 'E'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin C'), ('CHEBI_15948', 'lycopene', 288, 'lycopene'), ('GO_0007128', 'meiotic prophase I', 348, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 393, 'preterm'), ('GO_0007567', 'parturition', 401, 'birth')]
S147-PMC3171895	PMC3171895	9/2011	S147-PMC3171895	['a couple of subsequent RECENT multicentre double-blinded randomised trials of a combination of Vitamin C and E [130,131] also FOUND that supplementation did not reduce the rate of Preeclampsia or Gestational hypertension and, like the Vitamins in Preeclampsia trial in 2006 [132], increased the risk of fetal loss or Perinatal death and preterm prelabour rupture of Membranes.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 126)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 109, 'E'), ('GO_0007128', 'meiotic prophase I', 180, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 196, 'gestational'), ('CHEBI_28371', 'vitamin K epoxide', 235, 'Vitamins'), ('GO_0007128', 'meiotic prophase I', 247, 'Preeclampsia'), ('GO_0036268', 'swimming', 317, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 317, 'perinatal'), ('UBERON_0000922', 'embryo', 366, 'membranes')]
S38-PMC3277098	PMC3277098	12/2011	S38-PMC3277098	['Immune Cell Differentiation and Proliferation\nthe ROLE of Vitamin D in Regulation Of the Immune System was FIRST RECOGNIZED through the identification of Vitamin D receptors on Peripheral Blood Mononuclear cells (Lymphocytes) [2].']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 107), ('PROBABLE_UNDERSTANDING', 113)]	3	[('CL_0000902', 'induced T-regulatory cell', 0, 'Immune Cell'), ('GO_0002121', 'inter-male aggressive behavior', 0, 'Immune Cell Differentiation ... Proliferation'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007093', 'mitotic cell cycle checkpoint signaling', 71, 'regulation of ... immune system'), ('UBERON_0002405', 'immune system', 89, 'immune system'), ('CHEBI_28384', 'vitamin K', 154, 'Vitamin D'), ('UBERON_0012101', 'perinatal stage', 177, 'peripheral blood'), ('CL_0000100', 'motor neuron', 194, 'mononuclear'), ('GO_0031097', 'medial cortex', 194, 'mononuclear'), ('CL_0000542', 'lymphocyte', 213, 'lymphocytes')]
S94-PMC3407995	PMC3407995	7/2012	S94-PMC3407995	['Vitamin D insufficiency HAS BEEN ASSOCIATED with reduction in bone Mineral content of the offspring [51] and Perinatal growth restriction [52].']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('CHEBI_27300', 'vitamin D', 0, 'vitamin D'), ('CHEBI_46662', 'mineral', 67, 'mineral'), ('GO_0036268', 'swimming', 109, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 109, 'perinatal')]
S66-PMC3417531	PMC3417531	7/2012	S66-PMC3417531	"[""(91)childreninfectious diseasehigh rate of simkania negevensis among canadian inuit infants hospitalized with Lower Respiratory Tract infections (92)childrennutritioniron deficiency and anaemia prevalence and ASSOCIATED etiologic RISK FACTORS in first nations and inuit communities in northern ontario and nunavut (93)childrennutritionfood insecurity among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (59)childrennutritionvitamin D status of inuit preschoolers reflects season and Vitamin D intake (56)childrenenvironment/environmental exposures; infectious diseaseeffect of Prenatal exposure to Polychlorinated Biphenyls on incidence of acute Respiratory infections in preschool inuit children (25)childrenchronic disease; interventions/programmingthe benefits of sound field amplification in classrooms of inuit students of nunavik: a pilot project (73)childrensocial DETERMINANTS of health; tobaccocultural, socioeconomic, and health indicators among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (9)childreninfectious disease; tobaccoindoor air quality and the risk of Lower Respiratory Tract infections in young canadian inuit children (41)childreninfectious disease; interventions/programmingheat recovery ventilators prevent Respiratory disorders in inuit children (40)childrengenetics; nutritionadaptation of inuit children to a low-calcium diet (83)childreninfectious disease; health care, policy, Human resourcesbronchiolitis in inuit children from a canadian central arctic community, 1995–1996 (69)youthchronic diseasecauses and CONTRIBUTIONS to differences in Life expectancy for inuit nunangat and canada, 1994–2003 (82)youthinfectious diseaseotitis media and Hearing loss among 12–16 year-old inuit of inukjuak, quebec, canada (35)youthinjuryinjury mortality risk assessment and targeting the subpopulations for prevention in the northwest territories, canada (86)youthnutritionage differences in Vitamin A intake among canadian inuit (55)youthmental health and wellbeingcompleted suicides among the inuit of northern quebec, 1982–1996: a case-control study (77)youthmental health and wellbeing; social determinants of healthsuicidality in a sample of arctic households (76)youthinfectious disease; interventions/programminghiv testing experiences of aboriginal youth in canada: service IMPLICATIONS (74)youthinfections disease; social determinants of healthdeterminants of Sexually Transmitted infections among canadian inuit adolescent populations (30)youthinfections disease; mental health and wellbeingyouth sexual health in nunavut: a needs-based survey of knowledge, attitudes and behaviour (31)maternalbirth outcomesreclaiming Birth, health, and community: midwifery in the inuit villages of nunavik, canada (68)maternalenvironment/environmental exposuresorganochlorine levels in maternal and Umbilical Cord Blood Plasma in arctic canada (49)maternalenvironment/environmental exposuresexposure of the inuit population of nunavik (arctic quebec) to lead and mercury (48)maternalnutritiondietary assessment of indigenous canadian arctic women with a focus on Pregnancy and Lactation (54)maternalnutritioncontribution of selected traditional and market Foods to the diet of nunavik inuit women (57)maternalbirth outcomes; tobaccomaternal smoking at first Prenatal visit as a MARKER of risk for adverse Pregnancy outcomes in the qikiqtaaluk (baffin) region (8)maternalnutrition; environment/environmental exposuresfish Consumption and Blood Lipids in 3 ethnic groups of quebec (canada) (51)maternalhealth care, policy, Human resources; Birth outcomesconverging epistemologies: CRITICAL ISSUES in canadian inuit Childbirth and Pregnancy (65)maternalenvironment/environmental exposures; nutritiondeterminants of Polychlorinated Biphenyls and Methylmercury exposure in inuit women of Childbearing age (50)maternalhealth care, policy, Human resources; interventions/programmingthe outcome of Perinatal Care in inukjuak, nunavik, canada 1998–2002 (70)maternalhealth care, policy, Human resources; Birth outcomesthe inuulitsivik maternities: culturally appropriate midwifery and epistemological accommodation (66)maternalinfectious disease; interventions/programmingoncogenic human papillomavirus infection and Cervical lesions in aboriginal women in nunavut, canada (94)maternalchronic disease; social determinants of health; tobacco; mental health and Wellbeingthe health of cree, inuit and southern quebec women: similarities and differences (79)maternalnutrition; social DETERMINANTS of health; environment/environmental exposuresfood insecurity among inuit women exacerbated by socioeconomic stresses and climate change (60)children; youthchronic diseasethe RELATIONSHIP between socio-economic and geographic factors and asthma among canada's aboriginal populations (81)children; youthinfectious diseasehospitalization due to pneumonia among innu, inuit and non-aboriginal communities, newfoundland and labrador, canada (24)children; maternalbirth outcomesheart defects and other malformations in the inuit in canada: a baseline study (62)children; maternalbirth outcomesbirth outcomes in the inuit-inhabited areas of canada (95)children; maternalbirth outcomesdegree of rural isolation and Birth outcomes (63)children; maternalbirth outcomesrisks of adverse Pregnancy outcomes among inuit and north american indian women in quebec, 1985–97 (64)children; maternalenvironment/environmental exposuresprenatal exposure to Methylmercury and Pcbs AFFECTS distinct stages of information processing: an event-related POTENTIAL study with inuit children (44)children; maternalenvironment/environmental exposuresthe RELATION of lead neurotoxicity to the event-related potential p3b component in inuit children from arctic quebec (47)children; maternalenvironment/environmental exposuresthyroid hormone levels of Pregnant inuit women and their infants exposed to environmental contaminants (96)children; maternalenvironment/environmental exposuresneuromotor functions in inuit preschool children exposed to Pb, Pcbs, and hg (43)children; maternalenvironment/environmental exposuresbeneficial EFFECTS of a polyunsaturated Fatty Acid on infant development: EVIDENCE from the inuit of arctic quebec (52)children; maternalenvironment/environmental exposuresthe RELATION of environmental contaminants exposure to behavioural indicators in inuit preschoolers in arctic quebec (46)children; maternalinfectious diseaseneonatal Vitamin A deficiency and its IMPACT on acute Respiratory infections among preschool inuit children (33)children; maternalnutritionanaemia and iron status in inuit infants from northern quebec (97)children; maternalbirth outcomes; nutritioncongenital Heart defects in canadian inuit: is more Folic Acid making a difference?""]"	[('SUPERFICIAL_RELATIONSHIP', 209), ('SUPERFICIAL_RELATIONSHIP', 230), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1581), ('IMPORTANT_CONSIDERATION', 2342), ('SUPERFICIAL_RELATIONSHIP', 3334), ('IMPORTANT_CONSIDERATION', 3635), ('IMPORTANT_CONSIDERATION', 3644), ('SUPERFICIAL_RELATIONSHIP', 4527), ('SUPERFICIAL_RELATIONSHIP', 4715), ('SUPERFICIAL_RELATIONSHIP', 5499), ('INCOMPLETE_EVIDENCE', 5567), ('SUPERFICIAL_RELATIONSHIP', 5664), ('SUPERFICIAL_RELATIONSHIP', 6139), ('INCOMPLETE_EVIDENCE', 6202), ('SUPERFICIAL_RELATIONSHIP', 6304), ('SUPERFICIAL_RELATIONSHIP', 6495), ('EXPLICIT_QUESTION', 6787)]	18	[('UBERON_0004905', 'articulation', 110, 'lower respiratory tract'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 451, 'D'), ('CHEBI_27300', 'vitamin D', 502, 'vitamin D'), ('GO_0007565', 'female pregnancy', 596, 'prenatal'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 617, 'polychlorinated biphenyls'), ('UBERON_0001004', 'respiratory system', 665, 'respiratory'), ('UBERON_0004905', 'articulation', 1113, 'lower respiratory tract'), ('UBERON_0001004', 'respiratory system', 1272, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 1447, 'human'), ('UBERON_0000104', 'life cycle', 1613, 'life'), ('GO_0007605', 'sensory perception of sound', 1714, 'hearing'), ('CHEBI_27300', 'vitamin D', 1952, 'vitamin A'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 2429, 'sexually transmitted'), ('GO_0007567', 'parturition', 2689, 'birth'), ('UBERON_0002331', 'umbilical cord', 2855, 'umbilical cord'), ('UBERON_0000178', 'blood', 2870, 'blood'), ('UBERON_0001969', 'blood plasma', 2876, 'plasma'), ('GO_0007565', 'female pregnancy', 3119, 'pregnancy'), ('GO_0007595', 'lactation', 3133, 'lactation'), ('CHEBI_33290', 'food', 3212, 'foods'), ('GO_0007565', 'female pregnancy', 3314, 'prenatal'), ('GO_0007565', 'female pregnancy', 3361, 'pregnancy'), ('GO_0007631', 'feeding behavior', 3477, 'consumption'), ('UBERON_0000178', 'blood', 3493, 'blood'), ('CHEBI_18059', 'lipid', 3499, 'lipids'), ('NCBITaxon_9606', 'Homo sapiens', 3577, 'human'), ('GO_0007567', 'parturition', 3594, 'birth'), ('GO_0007623', 'circadian rhythm', 3669, 'childbirth'), ('GO_0007565', 'female pregnancy', 3684, 'pregnancy'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 3768, 'polychlorinated biphenyls'), ('CHEBI_33963', 'metallocene', 3798, 'methylmercury'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 3839, 'childbearing'), ('NCBITaxon_9606', 'Homo sapiens', 3889, 'human'), ('GO_0036356', 'cyclic 2,3-diphosphoglycerate synthetase activity', 3946, 'perinatal care'), ('UBERON_0012101', 'perinatal stage', 3946, 'perinatal'), ('NCBITaxon_9606', 'Homo sapiens', 4033, 'human'), ('GO_0007567', 'parturition', 4050, 'birth'), ('UBERON_0005434', 'cervical region', 4263, 'cervical'), ('GO_0035706', 'T-helper 1 cell chemotaxis', 4406, 'wellbeingThe'), ('GO_0007567', 'parturition', 5248, 'birth'), ('GO_0007565', 'female pregnancy', 5316, 'pregnancy'), ('CHEBI_33963', 'metallocene', 5476, 'methylmercury'), ('CHEBI_26199', 'polyprenol', 5494, 'PCBs'), ('GO_0007565', 'female pregnancy', 5860, 'pregnant'), ('CHEBI_37983', 'sulfur-35 atom', 6054, 'Pb'), ('CHEBI_26199', 'polyprenol', 6058, 'PCBs'), ('CHEBI_35366', 'fatty acid', 6168, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 6466, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 6511, 'respiratory'), ('UBERON_0000948', 'heart', 6716, 'heart'), ('CHEBI_30751', 'formic acid', 6757, 'folic acid')]
S134-PMC3515553	PMC3515553	12/2012	S134-PMC3515553	['conditioning on offspring genotype made this ASSOCIATION SOMEWHAT stronger, giving SUPPORT to the HYPOTHESIS that offspring iq score MAY BE INFLUENCED by maternal Vitamin B-12 status during the Intra-Uterine or Perinatal Period RATHER than REFLECT post-Natal offspring exposure to dietary Vitamin B-12.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228), ('SUPERFICIAL_RELATIONSHIP', 240)]	8	[('CHEBI_27300', 'vitamin D', 163, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 163, 'vitamin B-12'), ('UBERON_0001273', 'ilium', 194, 'intra'), ('UBERON_0000995', 'uterus', 200, 'uterine'), ('GO_0036268', 'swimming', 211, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 211, 'perinatal period'), ('GO_0007567', 'parturition', 253, 'natal'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 289, 'vitamin B-12')]
S202-PMC3552819	PMC3552819	12/2012	S202-PMC3552819	['the single Vitamin D3 dose of 70,000 iu did not provoke hypercalcemia or hypercalciuria in non-Pregnant or Pregnant participants, and available data INDICATED that adverse Perinatal events were neither temporally nor mechanistically linked to Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 149)]	1	[('CHEBI_33279', 'vitamin D5', 11, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 11, 'vitamin D3'), ('GO_0007565', 'female pregnancy', 95, 'pregnant'), ('GO_0007565', 'female pregnancy', 107, 'pregnant'), ('GO_0036268', 'swimming', 172, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 172, 'perinatal'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
S30-PMC3641012	PMC3641012	4/2013	S30-PMC3641012	['individuals were not eligible if they had any of the following exclusion criteria: use of any dietary supplement containing more than 400\xa0iu/day (10 mcg/day) of Vitamin D within the month prior to enrolment, or refusal to stop taking supplemental Vitamin D at any dose after enrollment; current use of anti-convulsant or Anti-Mycobacterial (tuberculosis) Medications; severe anemia (hemoglobin\u2009<\u200970\xa0g/l); systolic Blood pressure\u2009≥140\xa0mm hg or diastolic Blood pressure\u2009≥90\xa0mm hg; positive Urine dipstick for proteinuria or glycosuria; COMPLICATED medical or obstetric history; or, reported prior history of Delivery of an infant with a major congenital anomaly, Birth asphyxia, or Perinatal death.']	[('DIFFICULT_TASK', 534)]	1	[('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('CHEBI_59132', 'antigen', 321, 'anti'), ('CHEBI_52217', 'pharmaceutical', 326, 'mycobacterial'), ('CHEBI_25441', 'mycothiols', 355, 'medications'), ('UBERON_0000178', 'blood', 414, 'blood'), ('UBERON_0000178', 'blood', 453, 'blood'), ('UBERON_0001088', 'urine', 488, 'urine'), ('GO_0007567', 'parturition', 606, 'delivery'), ('GO_0007567', 'parturition', 661, 'birth'), ('GO_0036268', 'swimming', 680, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 680, 'perinatal')]
S41-PMC3672018	PMC3672018	5/2013	S41-PMC3672018	['ALTHOUGH mechanisms RELATING low Perinatal Vitamin D to later obesity are NOT WELL KNOWN, PROPOSED mediators include epigenetic changes leading to initiation of Adipogenesis, or induction of permanent functional changes in Hypothalamic Appetite Regulation [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 78), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 245)]	7	[('GO_0036268', 'swimming', 33, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 33, 'perinatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 161, 'adipogenesis'), ('UBERON_0001898', 'hypothalamus', 223, 'hypothalamic'), ('GO_0034205', 'amyloid-beta formation', 236, 'appetite regulation')]
S92-PMC3672018	PMC3672018	5/2013	S92-PMC3672018	['exposure assessment\nfour main analyses of exposure related to initiation and termination of Vitamin D fortification will be considered for each of the disease outcomes:\n1. Perinatal exposure to Vitamin D for offspring;\n2. seasonal variation in Vitamin D exposure in different Pregnancy trimesters;\n3. exposure to Vitamin D adjusted for Genetic and common environmental INFLUENCES;\n4. levels of Vitamin D (25(Oh)D3) measured in infant Blood from dbs cards.']	[('SUPERFICIAL_RELATIONSHIP', 369)]	1	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0036268', 'swimming', 172, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 172, 'perinatal'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('GO_0007565', 'female pregnancy', 276, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin D'), ('SO_0000704', 'gene', 336, 'genetic'), ('CHEBI_27300', 'vitamin D', 394, 'vitamin D'), ('CHEBI_62946', 'ammonium sulfate', 405, '25(OH)D3'), ('UBERON_0000178', 'blood', 434, 'blood')]
S51-PMC3702245	PMC3702245	6/2013	S51-PMC3702245	['further, there is a SUGGESTION of an ASSOCIATION between Vitamin D and Periodontal disease,90and maternal Serum 25(Oh)D < 75 nmol/l during Early Pregnancy HAS BEEN ASSOCIATED with a two-fold INCREASED risk of Periodontal disease.91in a RECENT randomized controlled TRIAL of Vitamin D supplementation from south carolina, Vitamin D supplementation of 4000 iu/day during Pregnancy was ASSOCIATED with a reduction in the risk of combined morbidities, such as Maternal infection, Preterm labor, and Preterm Birth.92\nIN VIEW of the POSSIBLE ASSOCIATION between maternal Vitamin D status and the pattern of fetal growth, pre-eclampsia, Gestational diabetes mellitus, and maternal infection, and the significant POTENTIAL for Perinatal morbidities ASSOCIATED with these conditions, evaluation of Vitamin D nutrition in early Pregnancy and the EFFECT of appropriate supplementation SEEMS WARRANTED.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 164), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 512), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 527), ('SUPERFICIAL_RELATIONSHIP', 536), ('INCOMPLETE_EVIDENCE', 705), ('SUPERFICIAL_RELATIONSHIP', 741), ('SUPERFICIAL_RELATIONSHIP', 836), ('ANOMALY_CURIOUS_FINDING', 874), ('FUTURE_WORK', 874)]	16	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001758', 'periodontium', 71, 'periodontal'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_71657', 'versiconol acetate', 112, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 112, '25(OH ... D'), ('GO_0051318', 'G1 phase', 139, 'early'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('UBERON_0001758', 'periodontium', 209, 'periodontal'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D'), ('GO_0007565', 'female pregnancy', 369, 'pregnancy'), ('GO_0007618', 'mating', 456, 'maternal'), ('GO_0007565', 'female pregnancy', 476, 'preterm'), ('GO_0007565', 'female pregnancy', 495, 'preterm'), ('GO_0007567', 'parturition', 503, 'birth'), ('CHEBI_27300', 'vitamin D', 565, 'vitamin D'), ('GO_0007565', 'female pregnancy', 630, 'gestational'), ('GO_0036268', 'swimming', 719, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 719, 'perinatal'), ('CHEBI_27300', 'vitamin D', 789, 'vitamin D'), ('GO_0007565', 'female pregnancy', 818, 'pregnancy')]
S17-PMC3705320	PMC3705320	3/2013	S17-PMC3705320	['the POSSIBLE ASSOCIATION between maternal-fetal Vitamin D status and infant health outcomes MAY be particularly relevant to south asian countries such as bangladesh, where adverse Perinatal outcomes and infant mortality are PUBLIC HEALTH PRIORITIES [10], and where Vitamin D deficiency HAS BEEN observed among women of Reproductive age [11] and young infants [12].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 224), ('IMPORTANT_CONSIDERATION', 238), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0036268', 'swimming', 180, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 180, 'perinatal'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('GO_0000003', 'reproduction', 319, 'reproductive')]
S25-PMC3705320	PMC3705320	3/2013	S25-PMC3705320	['reasons for exclusion were: preexisting medical condition; current Vitamin D supplement use; Anti-convulsant or anti-Mycobacterial medications; severe anemia (hemoglobin concentration <70 g/l); hypertension at enrollment (systolic Blood pressure ≥140 mmhg or diastolic Blood pressure ≥90 mmhg on at least two measurements); major risk FACTORS for Preterm Delivery or Pregnancy complications; or previous delivery of an infant with a congenital anomaly or Perinatal death.']	[('SUPERFICIAL_RELATIONSHIP', 335)]	1	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_59132', 'antigen', 93, 'anti'), ('CHEBI_52217', 'pharmaceutical', 117, 'mycobacterial'), ('UBERON_0000178', 'blood', 231, 'blood'), ('UBERON_0000178', 'blood', 269, 'blood'), ('GO_0007565', 'female pregnancy', 347, 'preterm'), ('GO_0007567', 'parturition', 355, 'delivery'), ('GO_0007565', 'female pregnancy', 367, 'pregnancy'), ('GO_0036268', 'swimming', 455, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 455, 'perinatal')]
S34-PMC3713405	PMC3713405	7/2013	S34-PMC3713405	['we begin with a concise summary of the epidemiological CLUES that SUGGEST altered Prenatal/Perinatal Vitamin D levels increase the risk of developing schizophrenia.']	[('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 66)]	2	[('GO_0007565', 'female pregnancy', 82, 'prenatal'), ('GO_0036268', 'swimming', 91, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 91, 'perinatal'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
S30-PMC3760821	PMC3760821	9/2013	S30-PMC3760821	['it HAS BEEN SPECULATED that SOME adverse Perinatal outcomes MAY BE due to the immunomodulatory properties of Vitamin D, which MAY assist in the appropriate Immune response to the Placenta[7].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 126)]	5	[('GO_0036268', 'swimming', 41, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 41, 'perinatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0002405', 'immune system', 156, 'immune'), ('UBERON_0001987', 'placenta', 179, 'placenta')]
S84-PMC3773018	PMC3773018	4/2013	S84-PMC3773018	['among subjects carrying the c Allele of rs2243250, persistently low Vitamin D status dramatically increased the RISK of fs, WHILE sufficient Vitamin D status during early childhood attenuated the risk of Perinatal Vitamin D deficiency on fs to null.']	[('IMPORTANT_CONSIDERATION', 112), ('ANOMALY_CURIOUS_FINDING', 124)]	2	[('SO_0001023', 'allele', 30, 'allele'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0036268', 'swimming', 204, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 204, 'perinatal'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
S25-PMC3798907	PMC3798907	8/2013	S25-PMC3798907	['given the REPORTED age RELATED DIFFERENTIAL responsiveness of Vitamin E on Human Th-Cell Responses [4,8], a secondary AIM of the study was TO INVESTIGATE the in vitro EFFECTS of Vitamins E and C on Adult Peripheral Blood Mononuclear Cell (Pbmc) responses.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 118), ('QUESTION_ANSWERED_BY_THIS_WORK', 139), ('SUPERFICIAL_RELATIONSHIP', 167)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin E'), ('NCBITaxon_9606', 'Homo sapiens', 75, 'human'), ('CL_0000545', 'T-helper 1 cell', 81, 'Th-cell'), ('GO_0001783', 'B cell apoptotic process', 81, 'Th-cell responses'), ('CHEBI_27300', 'vitamin D', 178, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 193, 'C'), ('PR_000004900', 'complement C3', 193, 'C'), ('UBERON_0007023', 'adult organism', 198, 'adult'), ('CL_0000111', 'peripheral neuron', 204, 'peripheral blood mononuclear cell'), ('UBERON_0012101', 'perinatal stage', 204, 'peripheral blood'), ('GO_0031097', 'medial cortex', 221, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 239, 'PBMC')]
S65-PMC3798907	PMC3798907	8/2013	S65-PMC3798907	['significant p values for differences in responses between paired samples in cultures with or without Vitamin E supplementation are shown on the RELEVANT panels.nutrients-05-03337-t001_table 1\n\ncaption (table-wrap): table 1\n\nsummary table representing the mean responses of cbmc and Peripheral Blood Mononuclear Cell (Pbmc) samples to control stimuli and Allergens, after supplementation with Vitamin E or Vitamin C. the mean change in response is shown for 70 cbmc samples and 18 pbmc samples, after supplementation with Vitamin E, and for 51 cbmc and 18 pbmc samples, after supplementation with Vitamin C. significant p values for differences in responses between paired samples in cultures with or without Vitamin E/Vitamin C supplementation are shown on the RELEVANT panels.Vitamin eprolififn-γil-4il-10Tgf-βvitamin cprolififn-γil-4il-10tgf-β cordcord tg↑ p< 0.05↓ p< 0.05↓↓↑tg↑↑↑ p< 0.05↓↓hdm↓↓↓↓↑hdm↓↑↑↓ p< 0.05↓con a↓↑↓↓↑con a↓ p< 0.05↑↑↓↓ppd↓ p< 0.001↓↑↓↑ppd↓↑ p< 0.05↑ p< 0.05↓ p< 0.05↓klh↓ p< 0.001↓↓↓↑klh↓↑↑ p< 0.05↓↓ adultadult tg↓↑↑↑↑tg↑ p< 0.05↑↑↓↑hdm↓↑↑↑↑ p< 0.05hdm↓↑↑↓↑con a↓↓↑↓↑ p< 0.05con a↑↓ p< 0.05↑↓ p< 0.05↑ppd↑↓↑↓↑ppd↓↑↑↓↑klh↓↓↑↑↑klh↓↑↑ p< 0.05↓↑\noverall, there was a TREND for Antigen or allergen cbmc cultures supplemented with Vitamin E to exhibit decreased secretion of the cytokines Ifn-Γ, il-10 and Il-4 (figure 1andtable 1), ALTHOUGH Production Of Tgf-Β did NOT fit this pattern and was GENERALLY increased.']	[('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 1191), ('ANOMALY_CURIOUS_FINDING', 1355), ('ANOMALY_CURIOUS_FINDING', 1388), ('PROBABLE_UNDERSTANDING', 1417)]	6	[('CHEBI_27300', 'vitamin D', 101, 'vitamin E'), ('CL_0000111', 'peripheral neuron', 282, 'peripheral blood mononuclear cell'), ('UBERON_0012101', 'perinatal stage', 282, 'peripheral blood'), ('GO_0031097', 'medial cortex', 299, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 317, 'PBMC'), ('CHEBI_33663', 'cyclic hydrocarbon', 354, 'allergens'), ('CHEBI_27300', 'vitamin D', 392, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 405, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 521, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 596, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 708, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 718, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 777, 'Vitamin'), ('PR_000000037', 'BMP receptor type-2', 803, '-10TGF'), ('CHEBI_59132', 'antigen', 1201, 'antigen'), ('CHEBI_27300', 'vitamin D', 1253, 'vitamin E'), ('PR_000008920', 'interferon alpha-7', 1311, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 1328, 'IL-4'), ('GO_0036309', 'protein localization to M-band', 1364, 'production of TGF-β'), ('PR_000000046', 'TGF-beta', 1378, 'TGF-β')]
S168-PMC3829803	PMC3829803	11/2013	S168-PMC3829803	['Perinatal Vitamin A Supplements in hiv-positive women CAN improve the survival of the seronegative children but CAN increase Mother-To-Child Hiv Transmission [65], POSSIBLY through increased Viral loads in Breast Milk [66].']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 164)]	3	[('GO_0036268', 'swimming', 0, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 0, 'Perinatal'), ('CHEBI_27300', 'vitamin D', 10, 'vitamin A'), ('CHEBI_33341', 'titanium atom', 20, 'supplements'), ('GO_0007063', 'regulation of sister chromatid cohesion', 125, 'mother-to-child HIV transmission'), ('NCBITaxon_1', 'root', 191, 'viral'), ('UBERON_0001348', 'brown adipose tissue', 206, 'breast milk')]
S22-PMC3882256	PMC3882256	1/2014	S22-PMC3882256	['furthermore, since Vitamin C is a key enhancer of iron absorption[24],[25], the RELATIONSHIP between Maternal iron intake and Perinatal or longer term outcomes may be stronger with adequate intake of Vitamin C[26].']	[('SUPERFICIAL_RELATIONSHIP', 80)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin C'), ('GO_0007618', 'mating', 101, 'maternal'), ('GO_0036268', 'swimming', 126, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 126, 'perinatal'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin C')]
S68-PMC3991049	PMC3991049	11/2013	S68-PMC3991049	['SEVERAL STUDIES have REPORTED ASSOCIATION between infant size and Vitamin D status.13,14reduced concentration of 25-Hydroxyvitamin D in mothers during late Pregnancy is ASSOCIATED with reduced Whole Body and Lumbar-Spine bone Mineral content in their children at the age of 9 years.15several studies HYPOTHESIZED that low Prenatal and Perinatal Vitamin D concentrations AFFECT the functional characteristics of various Tissues of the body, which leads to greater risk in later Life of multiple sclerosis, cancer, Insulin-dependent diabetes mellitus and schizophrenia.16,17\nthe current RECOMMENDED dose of Vitamin D during Pregnancy DIFFERS in DIFFERENT parts of the world.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 300), ('SUPERFICIAL_RELATIONSHIP', 370), ('FUTURE_WORK', 585), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 632), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643)]	9	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 113, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 156, 'pregnancy'), ('UBERON_0000468', 'multicellular organism', 193, 'whole body'), ('UBERON_0006074', 'lumbar region of vertebral column', 208, 'lumbar-spine'), ('CHEBI_46662', 'mineral', 226, 'mineral'), ('GO_0007565', 'female pregnancy', 322, 'prenatal'), ('GO_0036268', 'swimming', 335, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 335, 'perinatal'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0000479', 'tissue', 419, 'tissues'), ('UBERON_0000104', 'life cycle', 477, 'life'), ('PR_000045358', 'insulin family protein', 513, 'insulin'), ('CHEBI_27300', 'vitamin D', 605, 'vitamin D'), ('GO_0007565', 'female pregnancy', 622, 'pregnancy')]
S72-PMC4216020	PMC4216020	10/2014	S72-PMC4216020	['a larger prospective study, HOWEVER, DID NOT demonstrate an ASSOCIATED RISK between maternal smoking and jia.92\nOTHER Perinatal exposures and Pregnancy-related FACTORS HAVE BEEN investigated.47,92an australian study that reviewed 262 cases and matched controls IDENTIFIED a TREND towards a PROTECTIVE EFFECT with Prenatal Nutritional Supplements.47the mothers of children that eventually developed jia were less LIKELY to receive supplementation with Prenatal multivitamins (24.9% versus 30.8%), Vitamin D (3.3% versus 7.8%), Fish Oil (2.9% versus 6.4%), Calcium (10.2% versus 14.9%), Iron (35.4% versus 40.3%), and Folate (61.4% versus 64.8%) while Pregnant compared to controls.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 160), ('INCOMPLETE_EVIDENCE', 168), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 274), ('SUPERFICIAL_RELATIONSHIP', 290), ('SUPERFICIAL_RELATIONSHIP', 301), ('PROBABLE_UNDERSTANDING', 412)]	12	[('GO_0036268', 'swimming', 118, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 118, 'perinatal'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy'), ('GO_0007565', 'female pregnancy', 313, 'prenatal'), ('CHEBI_7495', 'nefazodone hydrochloride', 322, 'nutritional'), ('CHEBI_33341', 'titanium atom', 334, 'supplements'), ('GO_0007565', 'female pregnancy', 451, 'prenatal'), ('CHEBI_27300', 'vitamin D', 496, 'vitamin D'), ('CHEBI_34766', 'Furamizole', 526, 'fish oil'), ('CHEBI_22313', 'alkaline earth metal atom', 555, 'calcium'), ('CHEBI_24870', 'ion', 585, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 616, 'folate'), ('GO_0007565', 'female pregnancy', 650, 'pregnant')]
S173-PMC4329404	PMC4329404	10/2014	S173-PMC4329404	['a pilot STUDY of high-dose Vitamin D supplementation in Adults ( n \xa0=\xa04) HAS SHOWN an increase in circulating Il-10-producing Peripheral Blood Mononuclear Cells (Pbmcs) (37); HOWEVER, these were otherwise healthy subjects and only Circulating Cells were assessed.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0007023', 'adult organism', 56, 'adults'), ('PR_000001470', 'interleukin-28B', 110, 'IL-10'), ('UBERON_0012101', 'perinatal stage', 126, 'peripheral blood'), ('CL_0000226', 'single nucleate cell', 143, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 143, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 162, 'PBMCs'), ('CL_0000080', 'circulating cell', 231, 'circulating cells')]
S113-PMC4377870	PMC4377870	3/2015	S113-PMC4377870	['[94] examined the EFFECT of Α-Tocopherol and Vitamin C on cbmc and maternal Peripheral Blood Mononuclear Cells (Pbmc).']	[('SUPERFICIAL_RELATIONSHIP', 18)]	1	[('CHEBI_27725', 'butin', 28, 'α-tocopherol'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin C'), ('CL_0000111', 'peripheral neuron', 76, 'peripheral blood'), ('UBERON_0012101', 'perinatal stage', 76, 'peripheral blood'), ('CL_0000226', 'single nucleate cell', 93, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 93, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 112, 'PBMC')]
S7-PMC4380518	PMC4380518	9/2014	S7-PMC4380518	['introduction\nPerinatal health outcomes VARY dramatically by race in the united states.1african american women develop Preeclampsia more OFTEN than their white counterparts2and are more LIKELY to develop preterm labor.3the result is that black infants are 60% more LIKELY BE preterm and four times more LIKELY to die due to prematurity than white infants.1BECAUSE of less efficient Vitamin D Synthesis in the skin of darker Pigmented Individuals, african americans are at higher RISK than white americans of Vitamin D deficiency.4,5black women are also more LIKELY than white women to be overweight or obese6which is of CONCERN BECAUSE obesity is another RISK FACTOR for Vitamin D deficiency5,7and poor Perinatal outcomes.8in OBSERVATIONAL studies, 25-Hydroxyvitamin D (25[Oh]D) levels HAVE BEEN SHOWN to be ASSOCIATED with higher risk of several adverse Perinatal outcomes including Gestational diabetes9,10, preeclampsia,11preterm Birth12And small-for-Gestational age status.13,14,15,16,17BECAUSE of the PAUCITY of Vitamin D trial data with respect to Perinatal outcomes, WHETHER DIFFERENCES in Vitamin D status during Pregnancy explains or partially explains Perinatal DISPARITIES is PLAUSIBLE18but REMAINS UNKNOWN.']	[('DIFFICULT_TASK', 39), ('PROBABLE_UNDERSTANDING', 136), ('PROBABLE_UNDERSTANDING', 185), ('PROBABLE_UNDERSTANDING', 264), ('PROBABLE_UNDERSTANDING', 302), ('PROBABLE_UNDERSTANDING', 355), ('IMPORTANT_CONSIDERATION', 478), ('PROBABLE_UNDERSTANDING', 557), ('PROBLEM_COMPLICATION', 619), ('PROBABLE_UNDERSTANDING', 627), ('SUPERFICIAL_RELATIONSHIP', 654), ('INCOMPLETE_EVIDENCE', 725), ('INCOMPLETE_EVIDENCE', 785), ('SUPERFICIAL_RELATIONSHIP', 807), ('PROBABLE_UNDERSTANDING', 990), ('INCOMPLETE_EVIDENCE', 1005), ('EXPLICIT_QUESTION', 1073), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('IMPORTANT_CONSIDERATION', 1171), ('INCOMPLETE_EVIDENCE', 1186), ('FULL_UNKNOWN', 1201)]	21	[('GO_0036268', 'swimming', 13, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 13, 'Perinatal'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 381, 'vitamin D synthesis'), ('CHEBI_26130', 'biological pigment', 423, 'pigmented'), ('NCBITaxon_1', 'root', 433, 'individuals'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D'), ('GO_0036268', 'swimming', 702, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 702, 'perinatal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 748, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 769, '25[OH]D'), ('GO_0036268', 'swimming', 854, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 854, 'perinatal'), ('GO_0007565', 'female pregnancy', 883, 'gestational'), ('GO_0007594', 'puparial adhesion', 932, 'birth12and'), ('GO_0007565', 'female pregnancy', 953, 'gestational'), ('CHEBI_27300', 'vitamin D', 1016, 'vitamin D'), ('GO_0036268', 'swimming', 1053, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1053, 'perinatal'), ('CHEBI_27300', 'vitamin D', 1096, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1120, 'pregnancy'), ('GO_0036268', 'swimming', 1161, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1161, 'perinatal')]
S537-PMC4448820	PMC4448820	5/2015	S537-PMC4448820	['caption (table-wrap): table 6\n\neffects of Micronutrient supplementation on Immune function and vaccine responses (Human studies)1type of malnutrition and type of Immune functioneffects of supplementation on Immune System (reference)vitamin a\u2003Epithelial barrier function● high-dose vas above 6 mo of age decreases risk of death from infections such as measles and diarrheal diseases (290)● vas in the context of hiv infection or Lower Respiratory Tract infections HAS BEEN ASSOCIATED with adverse outcomes (105,263,290–292)● improved barrier function (105)● abnormal dual-Sugar (Lactulose, Mannitol) Intestinal permeability inversely CORRELATED with Serum Retinol (293) and PARTIALLY normalized by supplementation in va-deficient Individuals in SOME STUDIES (294) BUT NOT OTHERS (295,296)● increased symptomatology after high-dose vas during acute Lower Respiratory Tract infections REPORTED in SOME STUDIES (105) MAY INDICATE restored Mucus Production\u2003innate physiologic barriers● vas did not affect crp, saa, and/or agp concentrations among children with subclinical or clinical vad (297–299)● crp and agp did not change in men with low va stores given va (300)\u2003Macrophage function● increased Monocyte numbers (301)● decreased Tnf-Α concentrations in children (301) BUT the OPPOSITE in men (106)● decreased Ifn-Γ concentrations in children (302) but not in Pregnant women (303)● increased Il-10 concentrations in children (105,301) BUT no or an opposite effect in Adults (106,303,304)\u2003Neutrophil function● Neutrophil Phagocytosis of latex beads increased in va-deficient children given a single dose of Va (305)● Neutrophil Phagocytosis of E. Coli did not change in men with low Va stores given Va (300)\u2003Nk Cell function● an increase in Nk Cells in hiv-infected children supplemented with Va (105)● Nk Cell numbers did not change in men with low Va given supplemental Va; HOWEVER, there was a positive CORRELATION between Va stores and Peripheral Blood Nk Cells (300)\u2003T Cell function● increased Lymphocyte counts, particularly cd4 counts (105)● Cd4:Cd8 ratios were increased or unchanged by supplementation (306)● increase in Naive cd4 T Cells after supplementation; higher Memory Cd8, Cd45Ro (307)● higher Mitogen-induced Il-2, Il-4, and Tnf in response to supplementation (106)\u2003B Cell function● supplementation had no overall effect on Measles vaccine response (308) and a negative response in Individuals with baseline high titers (103)● no overall effect on oral polio vaccination● supplemented children increased Igg1 responses to dtp, minor igg3 response, no change in igg2 and igg4 (309)● no overall effect on bcg vaccine in Va-supplemented children, lower response in va-supplemented boys at 2 mo (310)● increased Antibody responses to some vaccines (Measles vaccine by 9 mo of age, oral polio vaccine, type 1, hepatitis b vaccine, rabies vaccine) (103)● short-term diminished cellular response to ppd in boys (103) and hospitalized children (105)Zinc\u2003Epithelial barrier function● zn supplementation in children LED TO an improvement in the lactulose:Mannitol Excretion ratio in SOME (311) BUT NOT OTHER (312,313) STUDIES; ratio MAY improve in infected children without zn deficiency given supplemental zn (314)\u2003innate physiologic barriers ● zn-supplemented children had higher Serum Complement C3 (315)\u2003Nk Cell function● children with diarrhea supplemented with zn supplementation do not exhibit an increase in Nk Cells (316)● increased Nk Cell activity in the elderly (317)\u2003T Cell function● increased cd4+ cell count in aids patients (318)● increased Thymocyte count in Thymus (319)● increased thymulin activity (320)● no CONSISTENT effect of zn supplementation on dth to tb Antigen [reviewed in (103)]\u2003B Cell function● no effect of zn supplementation of mothers on Bcg response in children (321)\nagp, α1-acid Glycoprotein; bcg, bacille calmette-guérin; cd, cluster of differentiation; Cd45Ro , Cluster Of Differentiation Antigen 45 Ro; Crp, c-reactive protein; dth, delayed-type hypersensitivity; dtp, diphtheria tetanus-pertussis; ppd, purified protein derivative; saa, Serum Amyloid a; tb, tuberculosis; va, Vitamin A; vad, Vitamin A deficiency; vas, Vitamin A supplementation.']	[('INCOMPLETE_EVIDENCE', 463), ('SUPERFICIAL_RELATIONSHIP', 472), ('SUPERFICIAL_RELATIONSHIP', 633), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 763), ('INCOMPLETE_EVIDENCE', 882), ('INCOMPLETE_EVIDENCE', 894), ('INCOMPLETE_EVIDENCE', 913), ('INCOMPLETE_EVIDENCE', 917), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1267), ('ANOMALY_CURIOUS_FINDING', 1267), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1433), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1873), ('SUPERFICIAL_RELATIONSHIP', 1903), ('SUPERFICIAL_RELATIONSHIP', 3021), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3088), ('INCOMPLETE_EVIDENCE', 3088), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3099), ('INCOMPLETE_EVIDENCE', 3123), ('INCOMPLETE_EVIDENCE', 3138), ('INCOMPLETE_EVIDENCE', 3633)]	23	"[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 42, 'micronutrient'), ('UBERON_0002405', 'immune system', 75, 'immune'), ('NCBITaxon_9606', 'Homo sapiens', 114, 'human'), ('UBERON_0002405', 'immune system', 162, 'immune'), ('UBERON_0002405', 'immune system', 207, 'immune system'), ('UBERON_0000483', 'epithelium', 242, 'Epithelial'), ('UBERON_0004905', 'articulation', 428, 'lower respiratory tract'), ('CHEBI_24870', 'ion', 571, 'sugar'), ('CHEBI_25098', 'lyxoside', 578, 'lactulose'), ('CHEBI_25169', 'mannoside', 589, 'mannitol'), ('UBERON_0000160', 'intestine', 599, 'intestinal'), ('UBERON_0001977', 'blood serum', 649, 'serum'), ('CHEBI_26536', 'retinoic acid', 655, 'retinol'), ('NCBITaxon_1', 'root', 729, 'individuals'), ('UBERON_0004905', 'articulation', 847, 'lower respiratory tract'), ('GO_0007498', 'mesoderm development', 935, 'mucus production'), ('UBERON_0000912', 'mucus', 935, 'mucus'), ('CL_0000235', 'macrophage', 1163, 'Macrophage'), ('CL_0000576', 'monocyte', 1194, 'monocyte'), ('PR_000000134', 'tumor necrosis factor alpha', 1228, 'TNF-α'), ('PR_000008920', 'interferon alpha-7', 1308, 'IFN-γ'), ('GO_0007565', 'female pregnancy', 1358, 'pregnant'), ('PR_000001470', 'interleukin-28B', 1390, 'IL-10'), ('UBERON_0007023', 'adult organism', 1465, 'adults'), ('CL_0000775', 'neutrophil', 1486, 'Neutrophil'), ('CL_0000775', 'neutrophil', 1507, 'Neutrophil'), ('GO_0007608', 'sensory perception of smell', 1507, 'Neutrophil'), ('GO_0006909', 'phagocytosis', 1518, 'phagocytosis'), ('CHEBI_37958', 'dye', 1604, 'VA'), ('CL_0000775', 'neutrophil', 1614, 'Neutrophil'), ('GO_0070231', 'T cell apoptotic process', 1614, 'Neutrophil phagocytosis'), ('NCBITaxon_10088', 'Mus <genus>', 1641, 'E. coli'), ('CHEBI_37958', 'dye', 1680, 'VA'), ('CHEBI_37958', 'dye', 1696, 'VA'), ('CL_0000623', 'natural killer cell', 1705, 'NK cell'), ('GO_0005634', 'nucleus', 1705, 'NK'), ('CL_0000623', 'natural killer cell', 1738, 'NK cells'), ('GO_0005634', 'nucleus', 1738, 'NK'), ('CHEBI_37958', 'dye', 1790, 'VA'), ('CL_0000623', 'natural killer cell', 1800, 'NK cell'), ('GO_0005634', 'nucleus', 1800, 'NK'), ('CHEBI_37958', 'dye', 1847, 'VA'), ('CHEBI_37958', 'dye', 1869, 'VA'), ('CHEBI_37958', 'dye', 1923, 'VA'), ('UBERON_0012101', 'perinatal stage', 1937, 'peripheral blood'), ('CL_0000623', 'natural killer cell', 1954, 'NK cells'), ('GO_0005634', 'nucleus', 1954, 'NK'), ('CL_0000084', 'T cell', 1969, 'T cell'), ('CL_0000542', 'lymphocyte', 1996, 'lymphocyte'), ('PR_000001204', 'C-C chemokine receptor type 8', 2046, 'CD4'), ('PR_000005170', 'CD37 molecule', 2050, 'CD8'), ('CL_0000898', 'naive T cell', 2127, 'naive ... T cells'), ('GO_0007613', 'memory', 2175, 'memory'), ('PR_000005170', 'CD37 molecule', 2182, 'CD8'), ('PR_000005170', 'CD37 molecule', 2187, 'CD45RO'), ('CHEBI_52290', 'mitogen', 2208, 'mitogen'), ('PR_000001470', 'interleukin-28B', 2224, 'IL-2'), ('PR_000001470', 'interleukin-28B', 2230, 'IL-4'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 2240, 'TNF'), ('CL_0000236', 'B cell', 2281, 'B cell'), ('NCBITaxon_33208', 'Metazoa', 2339, 'measles'), ('NCBITaxon_1', 'root', 2397, 'individuals'), ('GO_0071735', 'IgG immunoglobulin complex', 2519, 'IgG1'), ('CHEBI_37958', 'dye', 2633, 'VA'), ('GO_0042571', 'immunoglobulin complex, circulating', 2723, 'antibody'), ('NCBITaxon_33208', 'Metazoa', 2760, 'measles'), ('CHEBI_27377', ""Unsym-bis(4'-chlorophenyl)ethylene"", 2956, 'Zinc'), ('UBERON_0000483', 'epithelium', 2961, 'Epithelial'), ('CHEBI_25169', 'mannoside', 3060, 'mannitol'), ('GO_0007588', 'excretion', 3069, 'excretion'), ('UBERON_0001977', 'blood serum', 3287, 'serum'), ('PR_000004908', 'complement component C8 alpha chain', 3293, 'complement C3'), ('CL_0000623', 'natural killer cell', 3313, 'NK cell'), ('GO_0005634', 'nucleus', 3313, 'NK'), ('CL_0000623', 'natural killer cell', 3421, 'NK cells'), ('CL_0000623', 'natural killer cell', 3447, 'NK cell'), ('CL_0000084', 'T cell', 3485, 'T cell'), ('CL_0000893', 'thymocyte', 3562, 'thymocyte'), ('UBERON_0002370', 'thymus', 3581, 'thymus'), ('CHEBI_59132', 'antigen', 3686, 'antigen'), ('CL_0000236', 'B cell', 3714, 'B cell'), ('CHEBI_33250', 'atom', 3777, 'BCG'), ('CHEBI_17089', 'glycoprotein', 3821, 'glycoprotein'), ('PR_000005170', 'CD37 molecule', 3897, 'CD45RO'), ('PR_000011040', 'nuclear receptor coactivator 1', 3906, 'cluster of differentiation antigen 45 RO'), ('CHEBI_59132', 'antigen', 3933, 'antigen'), ('PR_000005890', 'crooked neck-like protein 1', 3948, 'CRP'), ('UBERON_0001977', 'blood serum', 4083, 'serum'), ('CHEBI_60425', 'amyloid fibril', 4089, 'amyloid'), ('CHEBI_27300', 'vitamin D', 4122, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4138, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4165, 'vitamin A')]"
S10-PMC4499946	PMC4499946	7/2015	S10-PMC4499946	['THIS TRIAL is expected to contribute unique INSIGHTS into the EFFECTS of improving maternal-infant Vitamin D status in a low-income setting where stunting and adverse Perinatal outcomes represent SIGNIFICANT PUBLIC HEALTH BURDENS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 196), ('IMPORTANT_CONSIDERATION', 208)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0036268', 'swimming', 167, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 167, 'perinatal')]
S26-PMC4499946	PMC4499946	7/2015	S26-PMC4499946	['THEREFORE, in bangladesh, we have OBSERVED that the period of greatest vulnerability with respect to Perinatal Vitamin D deficiency OVERLAPS with a critical period of fetal and early infant growth.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 132)]	3	[('GO_0036268', 'swimming', 101, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 101, 'perinatal'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
S48-PMC4499946	PMC4499946	7/2015	S48-PMC4499946	['clinical, biochemical, and microbiological Surveillance of enrolled mother-infant pairs will enable a range of secondary objectives to be addressed, including (1) estimation of the EFFECT of maternal Vitamin D supplementation on the incidence of acute Respiratory infections (aris) during early infancy; (2) exploration of the ROLES of specific hormones, Nutrients, environmental Contaminants, and inflammatory markers in the mediation or modification of the EFFECT of Vitamin D on fetal and infant growth, with particular emphasis on the ROLE of the Parathyroid hormone (pth) system; and (3) investigation of the ROLE of epigenetic modification of Genes involved in Perinatal Vitamin D Metabolism in infant stunting.']	[('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 327), ('SUPERFICIAL_RELATIONSHIP', 459), ('SUPERFICIAL_RELATIONSHIP', 539), ('SUPERFICIAL_RELATIONSHIP', 614)]	5	[('GO_0065007', 'biological regulation', 43, 'surveillance'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 252, 'respiratory'), ('CHEBI_33284', 'nutrient', 355, 'nutrients'), ('CHEBI_60688', 'EC 4.2.1.20 (tryptophan synthase) inhibitor', 380, 'contaminants'), ('CHEBI_27300', 'vitamin D', 469, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 551, 'parathyroid'), ('SO_0000704', 'gene', 649, 'genes'), ('GO_0036268', 'swimming', 667, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 667, 'perinatal'), ('CHEBI_27300', 'vitamin D', 677, 'vitamin D'), ('GO_0008152', 'metabolic process', 687, 'metabolism')]
S7-PMC4764019	PMC4764019	1/2016	S7-PMC4764019	['the barker HYPOTHESIS HAS BEEN ELABORATED and evaluated in several reviews,2–4BUT TO THE BEST OF MY KNOWLEDGE, there HAS BEEN NO ATTEMPT to evaluate the HYPOTHESIS specifically for Vitamin D. THUS, what i PROPOSE TO explore in THIS very brief REVIEW is the EVIDENCE RELATING UNRECOGNIZED, Perinatal Vitamin D inadequacy to increased risk of certain chronic diseases later in Life, that is, to ascertain WHETHER any such EFFECTS MIGHT be an instance of the “barker HYPOTHESIS.”\ni deliberately avoid use of labels such as “deficient” or “insufficient” in characterizing Vitamin D status, AS these terms are OFTEN LINKED to specific values for serum 25-Hydroxyvitamin D [25(Oh)D], about which there is considerable CONTROVERSY.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 153), ('PROBABLE_UNDERSTANDING', 192), ('INCOMPLETE_EVIDENCE', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 243), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 266), ('INCOMPLETE_EVIDENCE', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('SUPERFICIAL_RELATIONSHIP', 420), ('INCOMPLETE_EVIDENCE', 428), ('INCOMPLETE_EVIDENCE', 464), ('PROBABLE_UNDERSTANDING', 586), ('PROBABLE_UNDERSTANDING', 605), ('SUPERFICIAL_RELATIONSHIP', 611), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 712)]	25	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('GO_0036268', 'swimming', 289, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 289, 'perinatal'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('UBERON_0000104', 'life cycle', 375, 'life'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 647, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 668, '25(OH)D')]
S39-PMC4764019	PMC4764019	1/2016	S39-PMC4764019	['the OBSERVED ASSOCIATION is so strong that mcgrath et al ESTIMATED that 50% of the BURDEN of schizophrenia in the entire country of denmark COULD PERHAPS be ATTRIBUTED to PROBLEMS produced by low Perinatal Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 157), ('IMPORTANT_CONSIDERATION', 171)]	8	[('GO_0036268', 'swimming', 196, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 196, 'perinatal'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D')]
S75-PMC4764019	PMC4764019	1/2016	S75-PMC4764019	['BUT the fact is that HOW we function after Birth does APPEAR TO BE SUSCEPTIBLE to INFLUENCE by Perinatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 21), ('ANOMALY_CURIOUS_FINDING', 54), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('GO_0007567', 'parturition', 43, 'birth'), ('GO_0036268', 'swimming', 95, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 95, 'perinatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
S63-PMC4770602	PMC4770602	1/2016	S63-PMC4770602	['Preeclampsia is one of the LEADING CAUSES of Maternal and Perinatal Morbidity and mortality which, Vitamin D HAS BEEN HYPOTHESIZED to INFLUENCE Preeclampsia RISK.']	[('IMPORTANT_CONSIDERATION', 27), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 134), ('IMPORTANT_CONSIDERATION', 157)]	5	[('GO_0007128', 'meiotic prophase I', 0, 'Preeclampsia'), ('GO_0007618', 'mating', 45, 'maternal ...'), ('GO_0019230', 'proprioception', 58, 'perinatal morbidity'), ('UBERON_0012101', 'perinatal stage', 58, 'perinatal'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 144, 'preeclampsia')]
S156-PMC4846845	PMC4846845	4/2016	S156-PMC4846845	['a RECENT meta-analysis did NOT see a positive change in ptb, lbw, pre-eclampsia, and Gestational diabetes rates with Vitamin D supplementation, THOUGH they did CONCLUDE that Vitamin D has “PLAUSIBLE EFFECTS” on many Perinatal outcomes [119].']	[('INCOMPLETE_EVIDENCE', 2), ('ANOMALY_CURIOUS_FINDING', 27), ('ANOMALY_CURIOUS_FINDING', 144), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('GO_0007565', 'female pregnancy', 85, 'gestational'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0036268', 'swimming', 216, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 216, 'perinatal')]
S168-PMC4846845	PMC4846845	4/2016	S168-PMC4846845	['the EFFECTS of maternal Vitamin D levels MAY INFLUENCE Perinatal and long-term outcomes through immune, antibacterial, and anti-inflammatory responses [99,129].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0036268', 'swimming', 55, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 55, 'perinatal')]
S87-PMC4897157	PMC4897157	5/2016	S87-PMC4897157	['discussion\nwe HYPOTHESIZED that there MAY BE an ASSOCIATION between the Perinatal Vitamin D status and the development of Allergic Diseases.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('GO_0036268', 'swimming', 72, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 72, 'perinatal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0000381', 'regulation of alternative mRNA splicing, via spliceosome', 122, 'allergic diseases')]
S132-PMC4934634	PMC4934634	11/2015	S132-PMC4934634	['WHILE Vitamin D supplementation to women with Gestational diabetes improved Metabolic parameters, what IS NEEDED are clinical trials investigating the extent to WHICH Vitamin D supplementation decreases adverse Perinatal outcomes ASSOCIATED with Gestational diabetes including macrosomia, Respiratory distress, and Postnatal hypoglycemia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 103), ('EXPLICIT_QUESTION', 161), ('SUPERFICIAL_RELATIONSHIP', 230)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'gestational'), ('GO_0008152', 'metabolic process', 76, 'metabolic'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('GO_0036268', 'swimming', 211, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 211, 'perinatal'), ('GO_0007565', 'female pregnancy', 246, 'gestational'), ('UBERON_0001004', 'respiratory system', 289, 'respiratory'), ('GO_0007567', 'parturition', 315, 'postnatal')]
S13-PMC4971719	PMC4971719	8/2016	S13-PMC4971719	['FUTURE INVESTIGATIONS SHOULD study WHETHER Vitamin D supplementation in early Pregnancy MAY PREVENT Perinatal depressive symptoms.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 92)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0036268', 'swimming', 100, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 100, 'perinatal')]
S162-PMC4971719	PMC4971719	8/2016	S162-PMC4971719	['in the PUBLISHED LITERATURE, both low and high Vitamin D levels HAVE BEEN ASSOCIATED with Perinatal depression, a FINDING that others HAVE HYPOTHESIZED MAY BE due to a 24-hydroxylase-based degradation mechanism responding to abnormally high concentrations of Vitamin D [29].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 114), ('IMPORTANT_CONSIDERATION', 134), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 152)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0036268', 'swimming', 90, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 90, 'perinatal'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
S167-PMC4971719	PMC4971719	8/2016	S167-PMC4971719	['IF randomized studies SHOW a benefit for Vitamin D for PREVENTION or treatment of Perinatal depression, supplementation MAY benefit maternal fetal and neonatal health [49,50].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 120)]	4	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0036268', 'swimming', 82, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 82, 'perinatal')]
S12-PMC4973215	PMC4973215	8/2016	S12-PMC4973215	['far FEWER STUDIES have EXAMINED the RELATIONSHIP between Cord Blood Vitamin D levels, which MAY more ACCURATELY REFLECT fetal levels of Vitamin D, and neonatal outcomes.14,24GIVEN the racial DISPARITIES SEEN in both Vitamin D deficiency and Perinatal outcomes, Vitamin D HAS BEEN PROPOSED as part of the EXPLANATION for this DISPARITY, PARTICULARLY with regard to fetal growth and sga.8\nINCREASED AWARENESS of the GROWING PREVALENCE of maternal Vitamin D deficiency has LED TO an URGENT NEED for CONSIDERATION of supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 92), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 112), ('PROBABLE_UNDERSTANDING', 174), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 271), ('INCOMPLETE_EVIDENCE', 280), ('PROBABLE_UNDERSTANDING', 304), ('IMPORTANT_CONSIDERATION', 325), ('IMPORTANT_CONSIDERATION', 336), ('IMPORTANT_CONSIDERATION', 387), ('INCOMPLETE_EVIDENCE', 414), ('IMPORTANT_CONSIDERATION', 422), ('SUPERFICIAL_RELATIONSHIP', 470), ('IMPORTANT_CONSIDERATION', 480), ('FUTURE_WORK', 487), ('FUTURE_WORK', 496)]	21	[('UBERON_0002240', 'spinal cord', 57, 'cord'), ('UBERON_0000178', 'blood', 62, 'blood'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0036268', 'swimming', 241, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 241, 'perinatal'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0007565', 'female pregnancy', 536, 'pregnancy')]
S17-PMC4973215	PMC4973215	8/2016	S17-PMC4973215	['our GOAL was TO IDENTIFY specific high-risk subsets of Pregnant women who MAY BENEFIT from Vitamin D supplementation IN ORDER TO mitigate adverse Perinatal outcomes such as sga.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 74), ('IMPORTANT_CONSIDERATION', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 117)]	5	[('GO_0007565', 'female pregnancy', 55, 'pregnant'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0036268', 'swimming', 146, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 146, 'perinatal')]
S78-PMC4973215	PMC4973215	8/2016	S78-PMC4973215	['furthermore, this study was CONDUCTED in hamilton county, ohio, an area with worse Perinatal outcomes THAN national averages, including higher infant mortality, Preterm Birth and low Birth weight rates, as well as CONSIDERABLE racial DISPARITIES in infant mortality and Perinatal outcomes.34all of Cord Blood samples were collected over one winter season, THUS negating seasonal variations in Vitamin D levels that MAY have been SEEN in OTHER STUDIES.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('IMPORTANT_CONSIDERATION', 214), ('IMPORTANT_CONSIDERATION', 234), ('PROBABLE_UNDERSTANDING', 356), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 429), ('INCOMPLETE_EVIDENCE', 437)]	8	[('GO_0036268', 'swimming', 83, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 83, 'perinatal'), ('GO_0007565', 'female pregnancy', 161, 'preterm birth'), ('GO_0007567', 'parturition', 183, 'birth'), ('GO_0036268', 'swimming', 270, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 270, 'perinatal'), ('UBERON_0002240', 'spinal cord', 298, 'cord'), ('UBERON_0000178', 'blood', 303, 'blood'), ('CHEBI_27300', 'vitamin D', 393, 'vitamin D')]
S100-PMC4973215	PMC4973215	8/2016	S100-PMC4973215	['this WOULD have allowed for a more expansive definition of the RELATIONSHIP between maternal Vitamin D status and Perinatal outcomes.']	[('FUTURE_PREDICTION', 5), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('GO_0036268', 'swimming', 114, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 114, 'perinatal')]
S105-PMC4973215	PMC4973215	8/2016	S105-PMC4973215	['a GREATER UNDERSTANDING of the variables that INFLUENCE Vitamin D status during Pregnancy CAN have an immense PUBLIC HEALTH IMPACT in the reduction of adverse Perinatal outcomes such as sga.']	[('IMPORTANT_CONSIDERATION', 2), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 110), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0036268', 'swimming', 159, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 159, 'perinatal')]
S0-PMC4992225	PMC4992225	8/2016	S0-PMC4992225	['a randomized controlled trial of Vitamin D supplementation on Perinatal depression: in iranian Pregnant mothers\n\nabstract\n\nbackground\nMood disorders in Pregnancy and Post-Partum Period are common and CONSIDERED as a PUBLIC HEALTH ISSUE.']	[('IMPORTANT_CONSIDERATION', 200), ('IMPORTANT_CONSIDERATION', 216), ('IMPORTANT_CONSIDERATION', 230)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0036268', 'swimming', 62, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 62, 'perinatal'), ('GO_0007565', 'female pregnancy', 95, 'pregnant'), ('GO_0065007', 'biological regulation', 134, 'Mood'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy'), ('GO_0007565', 'female pregnancy', 166, 'post-partum'), ('UBERON_0001699', 'sensory root of facial nerve', 171, 'partum period')]
S1-PMC4992225	PMC4992225	8/2016	S1-PMC4992225	['researchers have studied the RELATIONSHIP between low Serum Vitamin D concentration and Perinatal depression, ALTHOUGH NO clinical trial HAS BEEN CONDUCTED on Vitamin D’s EFFECTS on depression RELATED to Childbirth.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('ANOMALY_CURIOUS_FINDING', 110), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 171), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0036268', 'swimming', 88, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 88, 'perinatal'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('GO_0007623', 'circadian rhythm', 204, 'childbirth')]
S48-PMC4992225	PMC4992225	8/2016	S48-PMC4992225	['CONSIDERING the POSSIBLE CONNECTION between low Serum Vitamin D and depression, researchers studied the RELATIONSHIP between low Vitamin D and Perinatal depression.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0036268', 'swimming', 143, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 143, 'perinatal')]
S63-PMC4992225	PMC4992225	8/2016	S63-PMC4992225	['ACCORDING TO OUR KNOWLEDGE, THERE WAS NO clinical trial that has evaluated the effectiveness of Vitamin D on Perinatal depression.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 10), ('FULL_UNKNOWN', 28)]	3	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0036268', 'swimming', 109, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 109, 'perinatal')]
S180-PMC4992225	PMC4992225	8/2016	S180-PMC4992225	['ACCORDING TO OUR KNOWLEDGE, this study was the FIRST trial held on Vitamin D and Perinatal depression.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 47)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0036268', 'swimming', 81, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 81, 'perinatal')]
S17-PMC5045784	PMC5045784	10/2016	S17-PMC5045784	['in addition, Animal studies SUPPORT the HYPOTHESIS that Vitamin D status MIGHT AFFECT the RISK of bpd GIVEN that both Vitamin D and the Vitamin D receptor (vdr) have IMPORTANT ROLES in Perinatal Lung Development.7,8thus, we SPECULATED that Vitamin D deficiency MIGHT predispose to and/or have a ROLE in the pathogenesis of bpd.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 90), ('PROBABLE_UNDERSTANDING', 102), ('IMPORTANT_CONSIDERATION', 166), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 261), ('SUPERFICIAL_RELATIONSHIP', 295)]	11	[('NCBITaxon_33208', 'Metazoa', 13, 'animal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0036268', 'swimming', 185, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 185, 'perinatal'), ('GO_0030324', 'lung development', 195, 'lung development'), ('UBERON_0002048', 'lung', 195, 'lung'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
S9-PMC5095257	PMC5095257	11/2016	S9-PMC5095257	['exposure to seasonal Viral infections in the Perinatal Period, coupled with Vitamin D deficiency, COULD lead to dysregulation of innate immunity AFFECTING the risk of developing aad.']	[('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 145)]	2	[('NCBITaxon_1', 'root', 21, 'viral'), ('GO_0036268', 'swimming', 45, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 45, 'perinatal period'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
S85-PMC5095257	PMC5095257	11/2016	S85-PMC5095257	['FURTHER STUDIES ARE REQUIRED to investigate the ASSOCIATION of Perinatal Vitamin D status and the RISK for aad.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('IMPORTANT_CONSIDERATION', 20), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 98)]	5	[('GO_0036268', 'swimming', 63, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 63, 'perinatal'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
S97-PMC5095257	PMC5095257	11/2016	S97-PMC5095257	['exposure to seasonal Viral infections in the Perinatal Period coupled with Vitamin D deficiency leading to dysregulation of innate immunity COULD BE the POTENTIAL initial triggers for the eventual development of aad, ALTHOUGH this REQUIRES FURTHER EXPLORATION.']	[('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 153), ('ANOMALY_CURIOUS_FINDING', 217), ('IMPORTANT_CONSIDERATION', 231), ('FUTURE_WORK', 240)]	5	[('NCBITaxon_1', 'root', 21, 'viral'), ('GO_0036268', 'swimming', 45, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 45, 'perinatal period'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
S14-PMC5115165	PMC5115165	1/2016	S14-PMC5115165	['introduction\npotatoes are the third most commonly Consumed Food crop in the world, after rice and wheat.1in the united states, about 35% of women of Reproductive Age (that is, aged 19-50) Consume potatoes daily, accounting FOR 8% of daily total energy intake.2the health EFFECTS of potatoes are INCONCLUSIVE,13and there HAVE BEEN longstanding DEBATES on the appropriate placement of potatoes in dietary guidance.456nonetheless, the dietary guidelines for americans continue to include potatoes in the vegetable Food group and encourage Consumption.7THOUGH potatoes are rich in Vitamin C, Potassium, dietary fiber, and some Phytochemicals,6unlike other vegetables they CAN have DETRIMENTAL EFFECTS on Glucose Metabolism because they contain large amounts of rapidly absorbable Starch.3indeed, SEVERAL epidemiologic STUDIES have LINKED higher potato Consumption to increased concentrations of fasting Plasma Glucose,8insulin resistance,8and an increased risk of type 2 diabetes mellitus.910\nGestational diabetes mellitus (gdm) is a common COMPLICATION of Pregnancy characterized by Glucose intolerance with onset or first recognition during Pregnancy.11gdm is not only ASSOCIATED with adverse Perinatal outcomes,12it is also RELATED to increased long term Cardiometabolic risk in both mothers and their offspring.1113it is THEREFORE CRUCIAL to identify modifiable RISK FACTORS that COULD CONTRIBUTE to the PREVENTION of gdm.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 223), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 320), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('ANOMALY_CURIOUS_FINDING', 548), ('INCOMPLETE_EVIDENCE', 668), ('IMPORTANT_CONSIDERATION', 677), ('SUPERFICIAL_RELATIONSHIP', 689), ('INCOMPLETE_EVIDENCE', 792), ('SUPERFICIAL_RELATIONSHIP', 827), ('PROBLEM_COMPLICATION', 1037), ('SUPERFICIAL_RELATIONSHIP', 1167), ('SUPERFICIAL_RELATIONSHIP', 1223), ('PROBABLE_UNDERSTANDING', 1321), ('IMPORTANT_CONSIDERATION', 1331), ('SUPERFICIAL_RELATIONSHIP', 1362), ('INCOMPLETE_EVIDENCE', 1380), ('SUPERFICIAL_RELATIONSHIP', 1386), ('SUPERFICIAL_RELATIONSHIP', 1404)]	20	[('GO_0007631', 'feeding behavior', 50, 'consumed'), ('CHEBI_33290', 'food', 59, 'food'), ('GO_0000003', 'reproduction', 149, 'reproductive age'), ('GO_0007631', 'feeding behavior', 188, 'consume'), ('CHEBI_33290', 'food', 511, 'food'), ('GO_0007631', 'feeding behavior', 536, 'consumption'), ('CHEBI_27300', 'vitamin D', 577, 'vitamin C'), ('CHEBI_22314', 'alkali metal atom', 588, 'potassium'), ('CHEBI_26254', 'prenylnaphthoquinone', 623, 'phytochemicals'), ('CHEBI_17234', 'glucose', 700, 'glucose'), ('GO_0006006', 'glucose metabolic process', 700, 'glucose metabolism'), ('CHEBI_28017', 'starch', 776, 'starch'), ('GO_0007631', 'feeding behavior', 848, 'consumption'), ('UBERON_0001969', 'blood plasma', 899, 'plasma'), ('CHEBI_17234', 'glucose', 906, 'glucose'), ('GO_0007565', 'female pregnancy', 989, 'Gestational'), ('GO_0007565', 'female pregnancy', 1053, 'pregnancy'), ('CHEBI_17234', 'glucose', 1080, 'glucose'), ('GO_0007565', 'female pregnancy', 1139, 'pregnancy'), ('GO_0036268', 'swimming', 1191, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1191, 'perinatal'), ('GO_0007599', 'hemostasis', 1254, 'cardiometabolic')]
S38-PMC5310660	PMC5310660	1/2017	S38-PMC5310660	['several seasonal factors acting during Pregnancy and the Perinatal Period HAVE BEEN PROPOSED to EXPLAIN these data, including infections, dietary factors (e.g., low intake of antioxidants in winter), and Vitamin D deficiency through lack of sun exposure during Pregnancy.[8].']	[('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 84), ('PROBABLE_UNDERSTANDING', 96)]	3	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('GO_0036268', 'swimming', 57, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 57, 'perinatal period'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('GO_0007565', 'female pregnancy', 261, 'pregnancy')]
S0-PMC5340372	PMC5340372	3/2017	S0-PMC5340372	['low Cord-Serum 25-Hydroxyvitamin D levels are ASSOCIATED with poor Lung function performance and increased Respiratory infection in infancy\n\nabstract\n\nbackground\nPerinatal Vitamin D deficiency is ASSOCIATED with a higher RISK of wheezing in childhood.']	[('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 196), ('IMPORTANT_CONSIDERATION', 221)]	3	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 15, '25-hydroxyvitamin D'), ('UBERON_0002048', 'lung', 67, 'lung'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory'), ('GO_0036268', 'swimming', 162, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 162, 'Perinatal'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
S2-PMC5340372	PMC5340372	3/2017	S2-PMC5340372	['the AIM of THIS STUDY was TO INVESTIGATE the IMPACT of Perinatal Vitamin D levels on Respiratory function and disease outcome in infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('GO_0036268', 'swimming', 55, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 55, 'perinatal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 85, 'respiratory')]
S26-PMC5340372	PMC5340372	3/2017	S26-PMC5340372	['the primary PURPOSE of this study was TO INVESTIGATE the EFFECT of Perinatal Vitamin D levels on the performance of Respiratory function in infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('GO_0036268', 'swimming', 67, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 67, 'perinatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 116, 'respiratory')]
S107-PMC5340372	PMC5340372	3/2017	S107-PMC5340372	['THEREFORE, drawing CONCLUSIONS about the EFFECTS of Perinatal and Postnatal Vitamin D status from these results can be DIFFICULT.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 19), ('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 119)]	4	[('GO_0036268', 'swimming', 52, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 52, 'perinatal'), ('GO_0007567', 'parturition', 66, 'postnatal'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
S117-PMC5340372	PMC5340372	3/2017	S117-PMC5340372	['in THIS STUDY, infants with low 25(Oh)D had higher rrs BUT SIMILAR vmaxfrc, which IMPLIES that low Perinatal Vitamin D levels MIGHT be ASSOCIATED with a higher resistance of the Extrathoracic Airway.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ANOMALY_CURIOUS_FINDING', 55), ('SUPERFICIAL_RELATIONSHIP', 59), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135)]	6	[('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('GO_0036268', 'swimming', 99, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 99, 'perinatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0001601', 'extra-ocular muscle', 178, 'extrathoracic airway')]
S148-PMC5340372	PMC5340372	3/2017	S148-PMC5340372	['we BELIEVE that THIS STUDY PROVIDES a CLEARER UNDERSTANDING of the EFFECT of Perinatal Vitamin D levels on Respiratory function and Respiratory outcome in infancy.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('PROBABLE_UNDERSTANDING', 27), ('PROBABLE_UNDERSTANDING', 38), ('SUPERFICIAL_RELATIONSHIP', 67)]	5	[('GO_0036268', 'swimming', 77, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 77, 'perinatal'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory'), ('UBERON_0001004', 'respiratory system', 132, 'respiratory')]
S112-PMC5359891	PMC5359891	3/2017	S112-PMC5359891	['secondary maternal outcomes of the initial phase of the nipper study are:\nmaintenance of a healthy Pregnancy, including normal duration of Gestation (at least 37\xa0weeks’ Gestation), absence of gdm (defined using the international association of the diabetes and Pregnancy study groups criteria: Glucose cut-off values of ≥5.1\xa0mmol/l for fasting Plasma Glucose, and/or ≥10.0\xa0mmol/l for 1-h and/or ≥8.5\xa0mmol/l for 2-h post load), change in fasting Glucose and ogtt Glucose area under the curve from Preconception baseline to 28\xa0weeks’ Gestation, maternal wellbeing/mood, absence of excessive nausea and vomiting, adequate Pregnancy weight gain (institute of medicine criteria) and Vaginal Delivery rates\nreduction in maternal Micronutrient insufficiency, specifically less riboflavin, Vitamin B6, Vitamin B12, zinc and Vitamin D insufficiency, before and during Pregnancy\nalteration in Gut microbiota CONSISTENT with enhanced wellbeing\nalteration in maternal metabolomic and epigenetic biomarkers CONSISTENT with improved maternal and/or offspring wellbeing\nenhancement of Breast Milk Micronutrient content, altered Immunological factors, epigenetic and metabolomic profiles (subsample) and maintenance of healthy Lactogenesis\nsecondary offspring outcomes of the initial phase of the nipper study are:\nneonatal adiposity measured by pea pod\nBirthweight 2500–4000\xa0g, size for Gestational age at Birth and customised birthweight centile\nreduced adiposity gain during Infancy, analysed taking account of infant Feeding\nreduction in Cord Blood c-peptide as a marker of overall glycaemia during Gestation\npromotion of offspring wellbeing and healthy Cardiometabolic RISK FACTORS, including Visceral adiposity and markers of Insulin resistance, during infancy\nalteration in offspring metabolomic and epigenetic biomarkers in Perinatal samples, CONSISTENT with improved infant Metabolic and allergic Wellbeing\nalteration in Gut microbiota to a microbiota ASSOCIATED with infant Metabolic and allergic Wellbeing\n\ndata and biosample collection\nstudy data will be collected by trained research staff using an access-controlled, web-based database (medscinet, stockholm) managed with support from the data management staff of the mrc Lifecourse epidemiology unit and the singapore institute for clinical sciences.']	[('INCOMPLETE_EVIDENCE', 898), ('INCOMPLETE_EVIDENCE', 994), ('SUPERFICIAL_RELATIONSHIP', 1658), ('INCOMPLETE_EVIDENCE', 1835), ('SUPERFICIAL_RELATIONSHIP', 1945)]	5	[('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('GO_0007565', 'female pregnancy', 139, 'gestation'), ('GO_0007565', 'female pregnancy', 169, 'gestation'), ('GO_0007565', 'female pregnancy', 261, 'Pregnancy'), ('CHEBI_17234', 'glucose', 294, 'glucose'), ('UBERON_0001969', 'blood plasma', 344, 'plasma'), ('CHEBI_17234', 'glucose', 351, 'glucose'), ('CHEBI_17234', 'glucose', 445, 'glucose'), ('CHEBI_17234', 'glucose', 462, 'glucose'), ('GO_0007565', 'female pregnancy', 496, 'preconception'), ('GO_0007565', 'female pregnancy', 532, 'gestation'), ('GO_0007565', 'female pregnancy', 619, 'pregnancy'), ('UBERON_0001987', 'placenta', 678, 'vaginal'), ('GO_0007567', 'parturition', 686, 'delivery'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 723, 'micronutrient'), ('CHEBI_33237', 'vitamin D4', 782, 'vitamin B6'), ('CHEBI_33279', 'vitamin D5', 794, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 816, 'vitamin D'), ('GO_0007565', 'female pregnancy', 859, 'pregnancy'), ('UBERON_0001555', 'digestive tract', 883, 'gut'), ('UBERON_0001348', 'brown adipose tissue', 1070, 'breast milk'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1082, 'micronutrient'), ('UBERON_0003222', 'flexor digitorum superficialis', 1113, 'immunological'), ('GO_0001554', 'luteolysis', 1211, 'lactogenesis'), ('GO_0007608', 'sensory perception of smell', 1338, 'Birthweight'), ('GO_0007565', 'female pregnancy', 1372, 'gestational'), ('GO_0007567', 'parturition', 1391, 'birth'), ('UBERON_0000023', 'wing', 1462, 'infancy'), ('GO_0007631', 'feeding behavior', 1505, 'feeding'), ('UBERON_0002240', 'spinal cord', 1526, 'cord'), ('UBERON_0000178', 'blood', 1531, 'blood'), ('GO_0007565', 'female pregnancy', 1587, 'gestation'), ('GO_0007599', 'hemostasis', 1642, 'cardiometabolic'), ('UBERON_0002075', 'viscus', 1682, 'visceral'), ('PR_000045358', 'insulin family protein', 1716, 'insulin'), ('GO_0036268', 'swimming', 1816, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1816, 'perinatal'), ('GO_0051238', 'sequestering of metal ion', 1867, 'metabolic ... wellbeing'), ('UBERON_0001555', 'digestive tract', 1914, 'gut'), ('GO_0051238', 'sequestering of metal ion', 1968, 'metabolic ... wellbeing'), ('UBERON_0001281', 'hepatic sinusoid', 2220, 'Lifecourse')]
S17-PMC5841533	PMC5841533	2/2018	S17-PMC5841533	['introduction\nan ESTIMATED 250\u2009million children GLOBALLY are denied the opportunity to reach their full developmental potential DUE TO the combined EFFECTS of poverty and undernutrition.1poor nutrition during Pregnancy CONTRIBUTES to maternal morbidity and mortality, increases the risks of low Birth weight and poor development, and exacerbates the risk of chronic disease in Adulthood.2 3many Pregnant women face Micronutrient deficiencies: an ESTIMATED 15.3% globally lack Vitamin A, 28.5% lack Iodine and 38% have iron-deficiency anaemia.1 4nutritional deprivation in Pregnancy CAN alter neural growth in the fetus and AFFECT Cognitive functioning, hindering children’s chances in school and CONTRIBUTING to the intergenerational transmission of poverty.5–9\nthe world health organisation (who) currently RECOMMENDS Iron and Folic Acid (ifa) supplementation in Pregnancy to improve maternal and Perinatal outcomes, BUT NOT multiple Micronutrient (mmn)supplementation.10–12could Antenatal Micronutrient supplementation improve children’s long-term Cognitive functioning?']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 47), ('PROBLEM_COMPLICATION', 127), ('SUPERFICIAL_RELATIONSHIP', 147), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 445), ('INCOMPLETE_EVIDENCE', 581), ('SUPERFICIAL_RELATIONSHIP', 622), ('SUPERFICIAL_RELATIONSHIP', 695), ('FUTURE_WORK', 807), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 917), ('ANOMALY_CURIOUS_FINDING', 917), ('EXPLICIT_QUESTION', 1070)]	13	[('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('GO_0007567', 'parturition', 294, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 376, 'adulthood'), ('GO_0007565', 'female pregnancy', 394, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 414, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 497, 'iodine'), ('GO_0007565', 'female pregnancy', 571, 'pregnancy'), ('GO_0050890', 'cognition', 629, 'cognitive'), ('CHEBI_24870', 'ion', 818, 'Iron'), ('CHEBI_30751', 'formic acid', 827, 'Folic Acid'), ('GO_0007565', 'female pregnancy', 863, 'pregnancy'), ('GO_0036268', 'swimming', 897, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 897, 'perinatal'), ('CHEBI_6956', 'Mitragynine', 934, 'Micronutrient'), ('GO_0007567', 'parturition', 980, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 990, 'micronutrient'), ('GO_0050890', 'cognition', 1049, 'cognitive')]
S21-PMC5958072	PMC5958072	5/2018	S21-PMC5958072	['several HYPOTHESES HAVE BEEN PROPOSED in the literature, including increased Perinatal influenza infection for those Born in the winter in new york city or decreased Perinatal Vitamin D exposure10,11.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 29)]	3	[('GO_0036268', 'swimming', 77, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 77, 'perinatal'), ('GO_0007567', 'parturition', 117, 'born'), ('GO_0036268', 'swimming', 166, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 166, 'perinatal'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D')]
